It exhibited greater effects in reducing weight, BMI, and BMI z-score, [12] and appeared to be the most effective and safest option among the four GLP-1 receptor agonists evaluated in children and adolescents with obesity or overweight [12,13]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.